The politics of prostate cancer screening
- PMID: 24725487
- DOI: 10.1016/j.ucl.2014.01.004
The politics of prostate cancer screening
Abstract
The controversial recent recommendation by the United States Preventive Services Task Force (USPSTF) against prostate-specific antigen (PSA) screening for early-stage prostate cancer has caused much debate. Whereas USPSTF recommendations against routine screening mammography in younger women resulted in fierce public outcry and eventual alteration in the language of the recommendation, the same public and political response has not been seen with PSA screening for prostate cancer. It is of paramount importance to ensure improved efficiency and transparency of the USPSTF recommendation process, and resolution of concerns with the current USPSTF recommendation against PSA screening for all ages.
Keywords: Localized; Prostate cancer; Prostate-specific antigen; Screening; United States Preventive Services Task Force.
Published by Elsevier Inc.
Similar articles
-
Screening for prostate cancer: U.S. Preventive Services Task Force recommendation statement.Ann Intern Med. 2012 Jul 17;157(2):120-34. doi: 10.7326/0003-4819-157-2-201207170-00459. Ann Intern Med. 2012. PMID: 22801674
-
Primary care physician PSA screening practices before and after the final U.S. Preventive Services Task Force recommendation.Urol Oncol. 2014 Jan;32(1):41.e23-30. doi: 10.1016/j.urolonc.2013.04.013. Epub 2013 Aug 2. Urol Oncol. 2014. PMID: 23911680
-
Impact of the 2012 United States Preventive Services Task Force statement on prostate-specific antigen screening: analysis of urologic and primary care practices.Urology. 2015 Jan;85(1):85-9. doi: 10.1016/j.urology.2014.07.072. Epub 2014 Nov 11. Urology. 2015. PMID: 25440819
-
Prostate Cancer Screening and the Associated Controversy.Surg Clin North Am. 2015 Oct;95(5):1023-39. doi: 10.1016/j.suc.2015.05.001. Epub 2015 Jun 23. Surg Clin North Am. 2015. PMID: 26315521 Review.
-
Impact of the United States Preventive Services Task Force 'D' recommendation on prostate cancer screening and staging.Curr Opin Urol. 2017 May;27(3):205-209. doi: 10.1097/MOU.0000000000000383. Curr Opin Urol. 2017. PMID: 28221220 Review.
Cited by
-
Prostate Cancer Screening.Med Clin North Am. 2018 Mar;102(2):199-214. doi: 10.1016/j.mcna.2017.11.001. Med Clin North Am. 2018. PMID: 29406053 Free PMC article. Review.
-
From 'D' to 'I': A critique of the current United States preventive services task force recommendation for testicular cancer screening.Prev Med Rep. 2016 Apr 21;3:361-6. doi: 10.1016/j.pmedr.2016.04.006. eCollection 2016 Jun. Prev Med Rep. 2016. PMID: 27419037 Free PMC article. Review.
-
Quantifying Gleason scores with photoacoustic spectral analysis: feasibility study with human tissues.Biomed Opt Express. 2015 Nov 9;6(12):4781-9. doi: 10.1364/BOE.6.004781. eCollection 2015 Dec 1. Biomed Opt Express. 2015. PMID: 26713193 Free PMC article.
-
Randomization to screening for prostate, lung, colorectal and ovarian cancers and thyroid cancer incidence in two large cancer screening trials.PLoS One. 2014 Sep 5;9(9):e106880. doi: 10.1371/journal.pone.0106880. eCollection 2014. PLoS One. 2014. PMID: 25192282 Free PMC article.
-
Implications of the new AUA guidelines on prostate cancer detection in the U.S.Curr Urol Rep. 2014 Jul;15(7):420. doi: 10.1007/s11934-014-0420-7. Curr Urol Rep. 2014. PMID: 24844775 Free PMC article.
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials
Miscellaneous
